A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease
Clinical trial NCT03351738 · COMPLETED
Trial details
- NCT number
- NCT03351738
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-13
- Primary completion
- 2018-11-09
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.